FLI1 and neoplasm: In the tumor microenvironment, ERG and FLI1 can be downregulated via the mixture of cytokines from many sources such as infiltrating immune cells (e.g. neutrophils, macrophages, and NK cells), ECs, CAFs, and tumor parenchyma.